Significance Type 1 diabetes (T1D) is known to be caused by immune destruction of insulin-producing β cells, but the disease pathogenesis remains poorly understood largely because of limitations in animal models to study the immunopathology. Here we established a humanized mouse T1D model, in which diabetes is driven by human T cells recognizing the HLA-DQ8–restricted insulin B chain peptide consisting of amino acids 9–23 (InsB:9–23). This study not only demonstrates the capacity of InsB:9–23-specific human CD4 T cells to initiate diabetes but also provides a preclinical humanized mouse model that has the potential to be used in studies of the immunopathogenesis and immunotherapy of T1D.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: